ABIO ARCA biopharma Inc.

1.15
+0.00  (0%)
Previous Close 1.15
Open 1.20
Price To book 1.13
Market Cap 16564812
Shares 14,404,184
Volume 23,575
Short Ratio 0.92
Av. Daily Volume 198,439

SEC filingsSee all SEC filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 171043500
  2. 8-K - Current report 171043473
  3. 8-K - Current report 171036977
  4. 8-K - Current report 171018699
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 171005412

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b completion of enrollment announced August 16, 2017 - top-line data due late 1Q 2018.
Gencaro - GENETIC-AF trial
Chronic Heart Failure

SEC Filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 171043500
  2. 8-K - Current report 171043473
  3. 8-K - Current report 171036977
  4. 8-K - Current report 171018699
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 171005412
  6. 8-K - Current report 171005207
  7. 8-K - Current report 17921006
  8. 8-K - Current report 17892101
  9. 8-K - Current report 17844561
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 17841366